Live Quote · NASDAQATYRHealthcare· Biotechnology

aTyr Pharma, Inc.

$0.59 0.46%(+$0.00)
TickerSpark Score
42/100
Weak
47
Valuation
20
Profitability
35
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATYR research report →

52-Week Range3% of range
Low
$0.40
Current
$0.59
High
$7.29
Company Overviewwww.atyrpharma.com

About the company

aTyr Pharma, Inc. , a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions.

CEO
Sanjay S. Shukla
IPO
2015
Employees
56
HQ
San Diego, CA, US

Price Chart

-88.78% · this period
$6.61$3.50$0.40Jul 02Dec 31Jul 02
Valuation
Market Cap
$58.10M
P/E
-0.83
P/S
305.76
P/B
1.00
EV/EBITDA
-0.87
Div Yield
0.00%
Profitability
Gross Margin
-11754.74%
Op Margin
-38573.68%
Net Margin
-36857.37%
ROE
-99.87%
ROIC
-105.54%
Growth & Income
Revenue
$190.00K · -19.15%
Net Income
$-74,118,000 · -15.77%
EPS
$-0.80 · 6.98%
Op Income
$-77,627,000
FCF YoY
10.29%
Performance & Tape
52W High
$7.29
52W Low
$0.40
50D MA
$0.60
200D MA
$0.78
Beta
0.54
Avg Volume
2.58M

Get TickerSpark's AI analysis on ATYR

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 27, 26SCHIMMEL PAULbuy100,000
May 11, 26Coughlin Timothyother50,000
May 11, 26BENEVICH ERICother50,000
May 11, 26Gross Jane Aother50,000
May 11, 26Lucas Svetlanaother50,000
May 11, 26Zaknoen Saraother50,000
May 11, 26SCHIMMEL PAULother50,000
Feb 3, 26Shukla Sanjayother10,375
Feb 4, 26Shukla Sanjaysell3,745
Feb 3, 26Shukla Sanjayother10,375
Coverage · ATYR

Our ATYR coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ATYR yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ATYR report →
Internal Compare

Similar companies

Peers in the same neighborhood.